Vimarsana
Biggest News Aggregation in the World

Page 9 - Hematologic Malignancies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hematologic Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hematologic Malignancies Today - Breaking & Trending Today

Unmet Needs in the Allogeneic Hematopoietic Stem Cell Transplant Population - Vimarsana News

Unmet Needs in the Allogeneic Hematopoietic Stem Cell Transplant Population

Identify remaining challenges and limitations of allo-HSCT that lead to suboptimal patient outcomes.

Ziftomenib Combos Show Early Safety, Activity in NPM1-Mutant and KMT2A-Rearranged AML - Vimarsana News

Ziftomenib Combos Show Early Safety, Activity in NPM1-Mutant and KMT2A-Rearranged AML

An acceptable safety profile and early evidence of clinical activity was observed with ziftomenib plus standard regimens in select patients with AML.

Graft-versus-Host Disease Prophylaxis and Management - Vimarsana News

Graft-versus-Host Disease Prophylaxis and Management

Focus on methods for preventing graft-versus-host disease (GvHD) following allo-HSCT, such as pharmacologic immune suppression and stem cell graft manipulation techniques.

Dr Davids on Treatment With Pirtobrutinib in CLL/SLL With/Without Prior BCL-2 Inhibitor Exposure - Vimarsana News

Dr Davids on Treatment With Pirtobrutinib in CLL/SLL With/Without Prior BCL-2 Inhibitor Exposure

Matthew S. Davids, MD, MMSc, discusses key efficacy results from 2 follow-up analyses of the phase 1/2 BRUIN trial evaluating pirtobrutinib.

CT Poses Risk for Malignant Hematopathies Among Children - Vimarsana News

CT Poses Risk for Malignant Hematopathies Among Children

Data suggest that risk increases even with low radiation doses.